Aegerion Pharmaceuticals, Inc.
(NASDAQ : AEGR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
1.56%44.690.9%$937.82m
JNJJohnson & Johnson
0.03%139.540.6%$924.87m
MRKMerck & Co., Inc.
0.15%72.320.6%$620.39m
LLYEli Lilly and Company
-0.77%112.441.0%$522.64m
ABBVAbbVie, Inc.
-0.78%89.202.2%$457.58m
BMYBristol-Myers Squibb Company
-2.04%54.841.4%$359.76m
NVSNovartis AG Sponsored ADR
1.32%87.380.2%$201.57m
AZNAstraZeneca PLC Sponsored ADR
0.90%39.301.3%$159.06m
GSKGlaxoSmithKline plc Sponsored ADR
3.00%40.800.2%$89.19m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.36%43.210.1%$88.44m
SNYSanofi Sponsored ADR
0.57%44.710.2%$59.35m
LCILannett Company, Inc.
0.78%3.9037.0%$6.49m
AKTXAkari Therapeutics Plc Sponsored ADR
3.34%1.921.7%$0.17m
EPIXESSA Pharma Inc
3.55%3.330.1%$0.03m

Company Profile

Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer and William H. Lewis on February 4, 2005 and is headquartered in Cambridge, MA.